The Enriched Environment as an Integrated Tool in the Ward Setting
ENVIRONMENT
1 other identifier
interventional
50
1 country
1
Brief Summary
The goal of this longitudinal interventional study is to integrate the enriched environment (EE) in the context of the Neurology Clinic ward of the General Hospital - University of Padua, by verifying its effectiveness and impact on psychological well-being, functional recovery, activity level, and quality of life in people with stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2023
CompletedFirst Posted
Study publicly available on registry
January 31, 2024
CompletedStudy Start
First participant enrolled
December 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedDecember 6, 2024
December 1, 2024
7 months
November 27, 2023
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stroke Impact Scale
The Stroke Impact Scale (SIS) is a self-report questionnaire that evaluates disability and health-related quality of life after stroke. SIS is a 59-item measure. Each item is rated in a 5-point Likert scale in terms of the difficulty the patient has experienced in completing each item. Summative scores are generated for each domain, scores range from 0-100.
T0: baseline (enrollment), T1: immediately after intervention (discharge), T2: 4 weeks post intervention (telephone interview), T3: 6 months post intervention (telephone interview)
Secondary Outcomes (10)
Functional Independence Measure (FIM) scale
T0: baseline (enrollment), T1: immediately after intervention (discharge), T2: 4 weeks post intervention (telephone interview), T3: 6 months post intervention (telephone interview)
Functional Assessment Test for Upper Limb
T0: baseline (enrollment), T1: immediately after intervention (discharge)
Functional Ambulatory Category (FAC)
T0: baseline (enrollment), T1: immediately after intervention (discharge), T2: 4 weeks post intervention (telephone interview), T3: 6 months post intervention (telephone interview)
Dynamic Gait Index (DGI) if FAC > 3
T0: baseline (enrollment), T1: immediately after intervention (discharge)
Oxford Cognitive Screening (OCS)
T0: baseline (enrollment), T1: immediately after intervention (discharge)
- +5 more secondary outcomes
Study Arms (2)
Enriched environment group
EXPERIMENTAL25 people with stroke recruited from the acute in-patient ward of the Neurology Clinic, meeting the inclusion criteria.
No intervention
NO INTERVENTION25 people with stroke recruited from the acute in-patient ward of the Neurology Clinic, meeting the inclusion criteria.
Interventions
In the experimental group (enriched environment), assistants will supervise participants sponatneoulsy engaging in activities, including listening to music, drawing, playing cards or board games, exercising the affected upper limb with constructions or puzzles, etc., in the living room and personal rooms. Posters and clocks will also aid in orientation and improve the physical environment.
Eligibility Criteria
You may qualify if:
- Ischaemic or haemorrhagic stroke, in any territory, occurring at least 24 hours before enrollment;
- Participant consent to participate in the study;
- Mecial stabilisation.
You may not qualify if:
- Uncooperative participant, as assessed by theMontreal Cognitive Assessment scale \< 15
- medically not stabtability and/or reduced level of consciousness and/or psychomotor agitation;
- Lack of trunk control (score \<12 in item 3 of the Trunk Control Test: balance in sitting position) such that it is impossible to maintain a sitting position or a safe posture in a wheelchair;
- Speech evaluation confirming comprehension aphasia hampering understanding of informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Teaching Hospital, University of Padova
Padua, 35128, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alessandra Del Felice, MD, PhD
University of Padova
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Physical and Rehabilitation Medicine
Study Record Dates
First Submitted
November 27, 2023
First Posted
January 31, 2024
Study Start
December 3, 2024
Primary Completion
June 30, 2025
Study Completion
November 30, 2025
Last Updated
December 6, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- Upon study completion
- Access Criteria
- Upon direct request of researchers providing any official reaserch identification (ORCID, Reaserch ID, etc)
Anonymized data sheet